These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy. Moriyama M, Matsumura H, Aoki H, Shimizu T, Yamagami H, Shioda A, Kaneko M, Goto I, Tanaka N, Arakawa Y. Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403 [Abstract] [Full Text] [Related]
9. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy. Shiffman ML, Stewart CA, Hofmann CM, Contos MJ, Luketic VA, Sterling RK, Sanyal AJ. J Infect Dis; 2000 Dec; 182(6):1595-601. PubMed ID: 11069229 [Abstract] [Full Text] [Related]
10. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy. Arase Y, Ikeda K, Tsubota A, Suzuki Y, Saitoh S, Kobayashi M, Suzuki F, Akuta N, Someya T, Hosaka T, Kobayashi M, Kumada H. J Gastroenterol; 2004 Dec; 39(5):455-60. PubMed ID: 15175944 [Abstract] [Full Text] [Related]
12. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. Tokita H, Fukui H, Tanaka A, Kamitsukasa H, Yagura M, Harada H, Okamoto H. J Gastroenterol Hepatol; 2005 May; 20(5):752-8. PubMed ID: 15853990 [Abstract] [Full Text] [Related]
14. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase. Sánchez-Conde M, Berenguer J, Miralles P, Alvarez F, Carlos Lopez J, Cosin J, Pilar C, Ramirez M, Gutierrez I, Alvarez E. Clin Infect Dis; 2006 Sep 01; 43(5):640-4. PubMed ID: 16886160 [Abstract] [Full Text] [Related]
16. Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Shiffman ML, Diago M, Tran A, Pockros P, Reindollar R, Prati D, Rodríguez-Torres M, Lardelli P, Blotner S, Zeuzem S. Clin Gastroenterol Hepatol; 2006 May 01; 4(5):645-52. PubMed ID: 16630770 [Abstract] [Full Text] [Related]
17. Effect of iron depletion on long-term response to interferon-alpha in patients with chronic hepatitis C who previously did not respond to interferon therapy. Tsai NC, Zuckerman E, Han SH, Goad K, Redeker AG, Fong TL. Am J Gastroenterol; 1997 Oct 01; 92(10):1831-4. PubMed ID: 9382046 [Abstract] [Full Text] [Related]
19. Therapy of hepatitis C: patients with normal aminotransferase levels. Marcellin P, Lévy S, Erlinger S. Hepatology; 1997 Sep 01; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678 [Abstract] [Full Text] [Related]
20. Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis. Rocha CM, Perez RM, Ferreira AP, Carvalho-Filho RJ, Pace FH, Silva IS, Pestana JO, Lanzoni VP, Silva AE, Ferraz ML. Liver Int; 2006 Apr 01; 26(3):305-10. PubMed ID: 16584392 [Abstract] [Full Text] [Related] Page: [Next] [New Search]